MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $810,000 | +8.6% | 18,591 | -10.0% | 0.00% | +33.3% |
| Q2 2023 | $746,000 | -9.6% | 20,650 | -6.9% | 0.00% | 0.0% |
| Q1 2023 | $825,000 | -20.4% | 22,187 | -3.0% | 0.00% | -25.0% |
| Q4 2022 | $1,036,000 | -31.3% | 22,875 | +5.9% | 0.00% | -42.9% |
| Q3 2022 | $1,508,000 | +4.9% | 21,594 | +0.8% | 0.01% | +16.7% |
| Q2 2022 | $1,438,000 | -19.6% | 21,424 | -1.6% | 0.01% | 0.0% |
| Q1 2022 | $1,789,000 | -46.0% | 21,762 | -3.6% | 0.01% | -45.5% |
| Q4 2021 | $3,310,000 | -14.6% | 22,563 | +3.0% | 0.01% | -21.4% |
| Q3 2021 | $3,876,000 | +7.1% | 21,908 | -2.2% | 0.01% | +7.7% |
| Q2 2021 | $3,618,000 | +2794.4% | 22,401 | +3850.8% | 0.01% | +1200.0% |
| Q4 2020 | $125,000 | – | 567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |